Evidence map›Paper›PMID 39253339›Full record

ReviewJournal of cardiovascular and thoracic research2024

Association of H-FABP with cardiovascular events: A systematic review.

Ambili Parekumbel Venu, Rajamanickam Rajkumar, Divakaran Dinesh Roy, Sreelal Thekkumkara Prabhakaran, Kanagasabapathy Shankar, Vidhyadharan Jayapal, Sureka Varalakshmi, Sreeja Sreenivasan

Abstract readReview
In one paragraph

Review in Journal of cardiovascular and thoracic research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ambili Parekumbel VenuResearch Scholar, Meenakshi Academy of Higher Education and Research (MAHER-Deemed to be University), West K.K Nagar, Chennai, Tamil Nadu, India.ORCID https://orcid.org/0009-0005-6220-2382
Rajamanickam RajkumarMeenakshi Medical College Hospital & Research Institute, Meenakshi Academy of Higher Education and Research (MAHER-Deemed to be University), Kanchipuram, Tamil Nadu, India.ORCID https://orcid.org/0000-0003-4904-8884
Divakaran Dinesh RoyGenetika Centre for Advanced Genetic Studies, Thiruvananthapuram, Kerala, India.ORCID https://orcid.org/0009-0005-7124-148X
Sreelal Thekkumkara PrabhakaranDr Moopen's Medical College, Wayanad, Kerala, India.
Kanagasabapathy ShankarMeenakshi Medical College Hospital & Research Institute, Meenakshi Academy of Higher Education and Research (MAHER-Deemed to be University), Kanchipuram, Tamil Nadu, India.
Vidhyadharan JayapalHridayalaya Heart Foundation, Thiruvananthapuram, Kerala, India.
Sureka VaralakshmiMeenakshi Medical College Hospital & Research Institute, Meenakshi Academy of Higher Education and Research (MAHER-Deemed to be University), Kanchipuram, Tamil Nadu, India.
Sreeja SreenivasanResearch Scholar, Meenakshi Academy of Higher Education and Research (MAHER-Deemed to be University), West K.K Nagar, Chennai, Tamil Nadu, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The research aimed to evaluate the association between heart-type fatty acid binding protein (H-FABP) and cardiovascular events. We systematically reviewed research that has been conducted to assess this relationship, aiming to determine how useful H-FABP could be as a biomarker for cardiovascular diseases, especially in the initial phases of acute myocardial infarction (AMI) and acute coronary syndrome (ACS). Our goal was to validate its diagnostic accuracy and clinical relevance. We systematically searched through PubMed, Web of Science, and Google Scholar databases to find pertinent publications related to cardiovascular diseases and H-FABP, using various permutations, abbreviations, and language variations of MeSH keywords. The final analysis included 12 studies in total. The final study comprised twelve studies, and it was concluded that H-FABP demonstrated high sensitivity (64.3-91.5) and specificity (73-100) for diagnosing Acute Myocardial Infarction (AMI) and Acute Coronary Syndrome (ACS), especially within the first hours of symptom onset. H-FABP demonstrates potential in enhancing the overall diagnostic accuracy during the initial hours following the manifestation of symptoms. However, the existing data do not provide sufficient evidence to recommend the regular utilization of H-FABP as a preliminary risk assessment approach in individuals who present with suspected cardiac events. Additional investigations, with well-defined prospective cohorts, are needed to validate the results observed.

Indexed as

Acute Coronary SyndromeAcute Myocardial InfarctionBiomarkerCoronary Artery DiseasesHeart-Type Fatty Acid-Binding ProteinH-FABP

Identifiers

PMID39253339
PMCPMC11380742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.